

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.87058990 |
| 2 | synaptic vesicle maturation (GO:0016188) | 3.80202848 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.62501325 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 3.49947076 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.49489778 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 3.49489778 |
| 7 | glutamate secretion (GO:0014047) | 3.46897749 |
| 8 | locomotory exploration behavior (GO:0035641) | 3.40320931 |
| 9 | vocalization behavior (GO:0071625) | 3.38933033 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 3.38541399 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.38541399 |
| 12 | cerebellar granule cell differentiation (GO:0021707) | 3.30391133 |
| 13 | neuronal action potential propagation (GO:0019227) | 3.29922472 |
| 14 | positive regulation of synapse maturation (GO:0090129) | 3.29307456 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.15715687 |
| 16 | neuronal ion channel clustering (GO:0045161) | 3.12488288 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.06207653 |
| 18 | proline transport (GO:0015824) | 3.03217113 |
| 19 | neurotransmitter secretion (GO:0007269) | 3.02894432 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.01140333 |
| 21 | gamma-aminobutyric acid transport (GO:0015812) | 3.00672333 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.99454440 |
| 23 | protein localization to synapse (GO:0035418) | 2.99106542 |
| 24 | regulation of ARF protein signal transduction (GO:0032012) | 2.95097404 |
| 25 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.89350531 |
| 26 | protein retention in ER lumen (GO:0006621) | 2.86910579 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 2.85985557 |
| 28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.84933738 |
| 29 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.82880319 |
| 30 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.81745037 |
| 31 | detection of calcium ion (GO:0005513) | 2.78977956 |
| 32 | layer formation in cerebral cortex (GO:0021819) | 2.78446527 |
| 33 | activation of protein kinase A activity (GO:0034199) | 2.76583953 |
| 34 | neuromuscular process controlling posture (GO:0050884) | 2.76510747 |
| 35 | positive regulation of dendritic spine development (GO:0060999) | 2.75973989 |
| 36 | exploration behavior (GO:0035640) | 2.75794781 |
| 37 | potassium ion homeostasis (GO:0055075) | 2.75483941 |
| 38 | regulation of synaptic vesicle transport (GO:1902803) | 2.73770134 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.73595640 |
| 40 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.73493222 |
| 41 | aromatic amino acid family catabolic process (GO:0009074) | 2.72614863 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 2.71507200 |
| 43 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.71487048 |
| 44 | creatine metabolic process (GO:0006600) | 2.70445665 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 2.70265890 |
| 46 | cell communication by electrical coupling (GO:0010644) | 2.69624084 |
| 47 | dendritic spine organization (GO:0097061) | 2.67841465 |
| 48 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.66414817 |
| 49 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.65059271 |
| 50 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.65059271 |
| 51 | alanine transport (GO:0032328) | 2.64690466 |
| 52 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.63593967 |
| 53 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.63456558 |
| 54 | glutamate metabolic process (GO:0006536) | 2.62649862 |
| 55 | regulation of synapse maturation (GO:0090128) | 2.60923017 |
| 56 | central nervous system myelination (GO:0022010) | 2.60808009 |
| 57 | axon ensheathment in central nervous system (GO:0032291) | 2.60808009 |
| 58 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.59947734 |
| 59 | bile acid biosynthetic process (GO:0006699) | 2.58887018 |
| 60 | coenzyme catabolic process (GO:0009109) | 2.58544240 |
| 61 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.57403688 |
| 62 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.57403688 |
| 63 | positive regulation of neurotransmitter transport (GO:0051590) | 2.57024887 |
| 64 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.56468679 |
| 65 | cellular sodium ion homeostasis (GO:0006883) | 2.55667700 |
| 66 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.54520139 |
| 67 | establishment of mitochondrion localization (GO:0051654) | 2.54084694 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 2.53791114 |
| 69 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.53677112 |
| 70 | positive regulation of membrane potential (GO:0045838) | 2.52499542 |
| 71 | cell migration in hindbrain (GO:0021535) | 2.52351192 |
| 72 | membrane depolarization during action potential (GO:0086010) | 2.51939391 |
| 73 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.50447604 |
| 74 | cell communication involved in cardiac conduction (GO:0086065) | 2.49853544 |
| 75 | cellular potassium ion homeostasis (GO:0030007) | 2.49366490 |
| 76 | potassium ion import (GO:0010107) | 2.49125676 |
| 77 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.48964627 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 2.48425010 |
| 79 | regulation of synaptic plasticity (GO:0048167) | 2.46611330 |
| 80 | synaptic vesicle endocytosis (GO:0048488) | 2.46411172 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.46336426 |
| 82 | response to gravity (GO:0009629) | 2.44525872 |
| 83 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.44166699 |
| 84 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.44129790 |
| 85 | sodium ion export (GO:0071436) | 2.43931881 |
| 86 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.43794071 |
| 87 | kynurenine metabolic process (GO:0070189) | 2.43660547 |
| 88 | dicarboxylic acid catabolic process (GO:0043649) | 2.43471080 |
| 89 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.43378544 |
| 90 | amino acid import (GO:0043090) | 2.42082086 |
| 91 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.41535294 |
| 92 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.39750108 |
| 93 | regulation of neurotransmitter secretion (GO:0046928) | 2.39112643 |
| 94 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.38247437 |
| 95 | neurotransmitter transport (GO:0006836) | 2.38056344 |
| 96 | lysine catabolic process (GO:0006554) | 2.36452994 |
| 97 | lysine metabolic process (GO:0006553) | 2.36452994 |
| 98 | regulation of neurotransmitter levels (GO:0001505) | 2.35981631 |
| 99 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.35962244 |
| 100 | high-density lipoprotein particle remodeling (GO:0034375) | 2.35958743 |
| 101 | L-amino acid import (GO:0043092) | 2.35735205 |
| 102 | glyoxylate metabolic process (GO:0046487) | 2.35696538 |
| 103 | detection of temperature stimulus (GO:0016048) | 2.34897389 |
| 104 | neuromuscular process controlling balance (GO:0050885) | 2.34048874 |
| 105 | mating behavior (GO:0007617) | 2.33493116 |
| 106 | glycine transport (GO:0015816) | 2.32967887 |
| 107 | negative regulation of fibrinolysis (GO:0051918) | 2.32414061 |
| 108 | postsynaptic membrane organization (GO:0001941) | 2.31051368 |
| 109 | positive regulation of dendrite development (GO:1900006) | 2.30856136 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 2.30841923 |
| 111 | aspartate family amino acid catabolic process (GO:0009068) | 2.30831289 |
| 112 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.30601042 |
| 113 | nucleobase catabolic process (GO:0046113) | 2.28483961 |
| 114 | regulation of protein activation cascade (GO:2000257) | 2.27995902 |
| 115 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.27628540 |
| 116 | complement activation, alternative pathway (GO:0006957) | 2.26338378 |
| 117 | dicarboxylic acid transport (GO:0006835) | 2.25860045 |
| 118 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.25570603 |
| 119 | mitochondrion transport along microtubule (GO:0047497) | 2.25570603 |
| 120 | auditory behavior (GO:0031223) | 2.24599744 |
| 121 | regulation of cholesterol metabolic process (GO:0090181) | 2.23592490 |
| 122 | sulfur amino acid catabolic process (GO:0000098) | 2.23177070 |
| 123 | ketone body metabolic process (GO:1902224) | 2.22567756 |
| 124 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.22108988 |
| 125 | long-term memory (GO:0007616) | 2.20832395 |
| 126 | 2-oxoglutarate metabolic process (GO:0006103) | 2.20513541 |
| 127 | innervation (GO:0060384) | 2.20441439 |
| 128 | regulation of cholesterol esterification (GO:0010872) | 2.20280260 |
| 129 | regulation of female receptivity (GO:0045924) | 2.19857693 |
| 130 | synaptic transmission, glutamatergic (GO:0035249) | 2.19783644 |
| 131 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.19748619 |
| 132 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.19604837 |
| 133 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.18238435 |
| 134 | glutamate receptor signaling pathway (GO:0007215) | 2.18145975 |
| 135 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.18099761 |
| 136 | fatty acid transmembrane transport (GO:1902001) | 2.17756378 |
| 137 | regulation of complement activation (GO:0030449) | 2.17738896 |
| 138 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.17427977 |
| 139 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.17297216 |
| 140 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.17277417 |
| 141 | protein carboxylation (GO:0018214) | 2.17277417 |
| 142 | neuron-neuron synaptic transmission (GO:0007270) | 2.16947381 |
| 143 | dendritic spine morphogenesis (GO:0060997) | 2.16808022 |
| 144 | regulation of postsynaptic membrane potential (GO:0060078) | 2.16477374 |
| 145 | short-chain fatty acid metabolic process (GO:0046459) | 2.16430696 |
| 146 | regulation of vesicle fusion (GO:0031338) | 2.16419064 |
| 147 | cerebellar Purkinje cell layer development (GO:0021680) | 2.16210917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.02097886 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.46063019 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65075179 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.60649591 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.48476727 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.46978683 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37783975 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37783975 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31033388 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.29345886 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.29190926 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28048393 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.25749407 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.24570418 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16413475 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.11991465 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.11201167 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10759481 |
| 19 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.07163259 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.07042218 |
| 21 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.00609278 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96962968 |
| 23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.96364584 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95894772 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95761989 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95354342 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.90867156 |
| 28 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.89350882 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.88896747 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.87943080 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83571862 |
| 32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.79103621 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.76172576 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.68694388 |
| 35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63913196 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62891039 |
| 37 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.48169829 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47714136 |
| 39 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.46067058 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.41654982 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38923752 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37368030 |
| 43 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34099532 |
| 44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33816827 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27797797 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.27411875 |
| 47 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24977041 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23218758 |
| 49 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.23094654 |
| 50 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.22091521 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.20609208 |
| 52 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.18980838 |
| 53 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17662972 |
| 54 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.17324247 |
| 55 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16011385 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.15812744 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15632155 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15146434 |
| 59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13916889 |
| 60 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12625182 |
| 61 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09619025 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08483775 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08096208 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08029900 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06741978 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06486982 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06029442 |
| 68 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05588836 |
| 69 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.05134756 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04843927 |
| 71 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04468890 |
| 72 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04396838 |
| 73 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04345190 |
| 74 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03543790 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03421893 |
| 76 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03341735 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03303992 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02943644 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02283913 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02218840 |
| 81 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01278743 |
| 82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.99976728 |
| 83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99764837 |
| 84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99352341 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98567183 |
| 86 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.98256809 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97555399 |
| 88 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96487487 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95468974 |
| 90 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95361917 |
| 91 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95200253 |
| 92 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.94557660 |
| 93 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93587718 |
| 94 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.93576434 |
| 95 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93270457 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93123412 |
| 97 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.92983488 |
| 98 | AR_19668381_ChIP-Seq_PC3_Human | 0.92913429 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92395965 |
| 100 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92265636 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92220095 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91888905 |
| 103 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.91203351 |
| 104 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90823889 |
| 105 | SA1_27219007_Chip-Seq_Bcells_Human | 0.89742753 |
| 106 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88861719 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88797948 |
| 108 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88002323 |
| 109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87464231 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86685971 |
| 111 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85856903 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85485195 |
| 113 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85264563 |
| 114 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.85005416 |
| 115 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.83940106 |
| 116 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83807944 |
| 117 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83281778 |
| 118 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.83027637 |
| 119 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82666842 |
| 120 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82577645 |
| 121 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.81262465 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.81219179 |
| 123 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.80871066 |
| 124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.79216676 |
| 125 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78998506 |
| 126 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.78812294 |
| 127 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.76926458 |
| 128 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.76220002 |
| 129 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.75434791 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.75042523 |
| 131 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.74985131 |
| 132 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.74654581 |
| 133 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74405223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.25312028 |
| 2 | MP0004270_analgesia | 3.18282673 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.09518605 |
| 4 | MP0003880_abnormal_central_pattern | 2.91482183 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 2.81794036 |
| 6 | MP0003122_maternal_imprinting | 2.72899452 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.70865487 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.64270080 |
| 9 | MP0005360_urolithiasis | 2.61846744 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.48549444 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.45195203 |
| 12 | MP0002822_catalepsy | 2.38261604 |
| 13 | MP0009745_abnormal_behavioral_response | 2.30306922 |
| 14 | MP0002736_abnormal_nociception_after | 2.28048113 |
| 15 | MP0004858_abnormal_nervous_system | 2.20614441 |
| 16 | MP0002064_seizures | 2.20095453 |
| 17 | MP0003329_amyloid_beta_deposits | 2.18946510 |
| 18 | MP0002063_abnormal_learning/memory/cond | 2.18551833 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.17046382 |
| 20 | MP0005365_abnormal_bile_salt | 2.15705575 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 2.12742729 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.10389438 |
| 23 | MP0009046_muscle_twitch | 2.07606634 |
| 24 | MP0000751_myopathy | 2.05820355 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.96884841 |
| 26 | MP0005083_abnormal_biliary_tract | 1.94147970 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.92023178 |
| 28 | MP0002272_abnormal_nervous_system | 1.89967239 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.83377723 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.80740544 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.74925616 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.72166295 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.69480989 |
| 34 | MP0004130_abnormal_muscle_cell | 1.68596657 |
| 35 | MP0001970_abnormal_pain_threshold | 1.67335790 |
| 36 | MP0003123_paternal_imprinting | 1.67190178 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.66510622 |
| 38 | MP0005167_abnormal_blood-brain_barrier | 1.62004631 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.60221272 |
| 40 | MP0002638_abnormal_pupillary_reflex | 1.59554443 |
| 41 | MP0001486_abnormal_startle_reflex | 1.55518876 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.44332862 |
| 43 | MP0000604_amyloidosis | 1.40666949 |
| 44 | MP0009840_abnormal_foam_cell | 1.33081271 |
| 45 | MP0002184_abnormal_innervation | 1.30338546 |
| 46 | MP0000747_muscle_weakness | 1.29833397 |
| 47 | MP0005332_abnormal_amino_acid | 1.28840659 |
| 48 | MP0005535_abnormal_body_temperature | 1.28270574 |
| 49 | MP0000749_muscle_degeneration | 1.27410167 |
| 50 | MP0005423_abnormal_somatic_nervous | 1.24997869 |
| 51 | MP0003195_calcinosis | 1.23109427 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.23096548 |
| 53 | MP0000955_abnormal_spinal_cord | 1.22658402 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.22542336 |
| 55 | MP0004036_abnormal_muscle_relaxation | 1.21794862 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.20651608 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.19398571 |
| 58 | MP0003646_muscle_fatigue | 1.18570374 |
| 59 | MP0005386_behavior/neurological_phenoty | 1.17419507 |
| 60 | MP0004924_abnormal_behavior | 1.17419507 |
| 61 | MP0003633_abnormal_nervous_system | 1.14142086 |
| 62 | MP0008569_lethality_at_weaning | 1.13203035 |
| 63 | MP0003252_abnormal_bile_duct | 1.10300737 |
| 64 | MP0008874_decreased_physiological_sensi | 1.08928759 |
| 65 | MP0003879_abnormal_hair_cell | 1.07995497 |
| 66 | MP0002066_abnormal_motor_capabilities/c | 1.07661263 |
| 67 | MP0004142_abnormal_muscle_tone | 1.07294322 |
| 68 | MP0005451_abnormal_body_composition | 1.06689603 |
| 69 | MP0003690_abnormal_glial_cell | 1.04188716 |
| 70 | MP0002557_abnormal_social/conspecific_i | 1.03812709 |
| 71 | MP0010386_abnormal_urinary_bladder | 1.03214599 |
| 72 | MP0001502_abnormal_circadian_rhythm | 1.02376291 |
| 73 | MP0004085_abnormal_heartbeat | 1.02030215 |
| 74 | MP0002269_muscular_atrophy | 0.99750394 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99611890 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 0.99341080 |
| 77 | MP0005620_abnormal_muscle_contractility | 0.96959952 |
| 78 | MP0000778_abnormal_nervous_system | 0.94864686 |
| 79 | MP0008961_abnormal_basal_metabolism | 0.94850029 |
| 80 | MP0002882_abnormal_neuron_morphology | 0.94350512 |
| 81 | MP0003137_abnormal_impulse_conducting | 0.93769191 |
| 82 | MP0002090_abnormal_vision | 0.93202039 |
| 83 | MP0003631_nervous_system_phenotype | 0.92572742 |
| 84 | MP0000681_abnormal_thyroid_gland | 0.92261116 |
| 85 | MP0002971_abnormal_brown_adipose | 0.92123681 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.91803971 |
| 87 | MP0001984_abnormal_olfaction | 0.91796751 |
| 88 | MP0003279_aneurysm | 0.91200740 |
| 89 | MP0008260_abnormal_autophagy | 0.90820777 |
| 90 | MP0002653_abnormal_ependyma_morphology | 0.90446327 |
| 91 | MP0003075_altered_response_to | 0.89385982 |
| 92 | MP0003191_abnormal_cellular_cholesterol | 0.89305842 |
| 93 | MP0005670_abnormal_white_adipose | 0.89264417 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.89148925 |
| 95 | MP0004084_abnormal_cardiac_muscle | 0.89066374 |
| 96 | MP0001529_abnormal_vocalization | 0.87610570 |
| 97 | MP0005330_cardiomyopathy | 0.86070441 |
| 98 | MP0002295_abnormal_pulmonary_circulatio | 0.85901447 |
| 99 | MP0004885_abnormal_endolymph | 0.84918383 |
| 100 | MP0002229_neurodegeneration | 0.84211897 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 0.83733698 |
| 102 | MP0002069_abnormal_eating/drinking_beha | 0.83056622 |
| 103 | MP0002078_abnormal_glucose_homeostasis | 0.81812191 |
| 104 | MP0003634_abnormal_glial_cell | 0.81232197 |
| 105 | MP0004087_abnormal_muscle_fiber | 0.80931315 |
| 106 | MP0002972_abnormal_cardiac_muscle | 0.80739487 |
| 107 | MP0000678_abnormal_parathyroid_gland | 0.79878242 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.79177487 |
| 109 | MP0004233_abnormal_muscle_weight | 0.78673917 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.78561574 |
| 111 | MP0005646_abnormal_pituitary_gland | 0.77979305 |
| 112 | MP0001905_abnormal_dopamine_level | 0.77961644 |
| 113 | MP0000920_abnormal_myelination | 0.76990388 |
| 114 | MP0003283_abnormal_digestive_organ | 0.76356721 |
| 115 | MP0004510_myositis | 0.75384221 |
| 116 | MP0000759_abnormal_skeletal_muscle | 0.74666639 |
| 117 | MP0000230_abnormal_systemic_arterial | 0.72192459 |
| 118 | MP0005448_abnormal_energy_balance | 0.72117263 |
| 119 | MP0004742_abnormal_vestibular_system | 0.71863732 |
| 120 | MP0008872_abnormal_physiological_respon | 0.70527218 |
| 121 | MP0003632_abnormal_nervous_system | 0.69901993 |
| 122 | MP0001963_abnormal_hearing_physiology | 0.69497487 |
| 123 | MP0005409_darkened_coat_color | 0.68703005 |
| 124 | MP0001958_emphysema | 0.67099815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.24925993 |
| 2 | Focal motor seizures (HP:0011153) | 4.16146519 |
| 3 | Focal seizures (HP:0007359) | 3.50744124 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.46592365 |
| 5 | Deep venous thrombosis (HP:0002625) | 3.36680059 |
| 6 | Abnormality of binocular vision (HP:0011514) | 3.36091557 |
| 7 | Diplopia (HP:0000651) | 3.36091557 |
| 8 | Visual hallucinations (HP:0002367) | 3.21063936 |
| 9 | Pheochromocytoma (HP:0002666) | 3.06197160 |
| 10 | Action tremor (HP:0002345) | 3.03486012 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.00825015 |
| 12 | Xanthomatosis (HP:0000991) | 2.97579450 |
| 13 | Atonic seizures (HP:0010819) | 2.96324049 |
| 14 | Neurofibrillary tangles (HP:0002185) | 2.86468217 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 2.83327541 |
| 16 | Polyphagia (HP:0002591) | 2.80850951 |
| 17 | Exercise-induced myalgia (HP:0003738) | 2.77615772 |
| 18 | Peripheral hypomyelination (HP:0007182) | 2.74844962 |
| 19 | Abnormality of the lower motor neuron (HP:0002366) | 2.73650341 |
| 20 | Cerebral inclusion bodies (HP:0100314) | 2.70592407 |
| 21 | Ketosis (HP:0001946) | 2.70049392 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 2.66200522 |
| 23 | Absence seizures (HP:0002121) | 2.60341052 |
| 24 | Neuroendocrine neoplasm (HP:0100634) | 2.60238423 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 2.55889934 |
| 26 | Complement deficiency (HP:0004431) | 2.55610542 |
| 27 | Hyperthyroidism (HP:0000836) | 2.55483325 |
| 28 | Cholecystitis (HP:0001082) | 2.54572873 |
| 29 | Abnormal gallbladder physiology (HP:0012438) | 2.54572873 |
| 30 | Ankle clonus (HP:0011448) | 2.50116205 |
| 31 | Ketoacidosis (HP:0001993) | 2.49477665 |
| 32 | Progressive cerebellar ataxia (HP:0002073) | 2.47545321 |
| 33 | Torticollis (HP:0000473) | 2.45891142 |
| 34 | Epileptic encephalopathy (HP:0200134) | 2.45657687 |
| 35 | Akinesia (HP:0002304) | 2.43564942 |
| 36 | Dialeptic seizures (HP:0011146) | 2.40687975 |
| 37 | Mutism (HP:0002300) | 2.39978707 |
| 38 | Papilledema (HP:0001085) | 2.37768002 |
| 39 | Sudden death (HP:0001699) | 2.37003380 |
| 40 | Anxiety (HP:0000739) | 2.36905706 |
| 41 | Growth hormone excess (HP:0000845) | 2.35403540 |
| 42 | Febrile seizures (HP:0002373) | 2.35087575 |
| 43 | Impaired social interactions (HP:0000735) | 2.33305953 |
| 44 | Abnormal social behavior (HP:0012433) | 2.33305953 |
| 45 | Status epilepticus (HP:0002133) | 2.32254648 |
| 46 | Myotonia (HP:0002486) | 2.31861720 |
| 47 | Hyperventilation (HP:0002883) | 2.30570948 |
| 48 | Clonus (HP:0002169) | 2.30462535 |
| 49 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.30210618 |
| 50 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.28943374 |
| 51 | Joint hemorrhage (HP:0005261) | 2.28861642 |
| 52 | Depression (HP:0000716) | 2.28228021 |
| 53 | Hyperammonemia (HP:0001987) | 2.27679727 |
| 54 | Neuronal loss in central nervous system (HP:0002529) | 2.25949232 |
| 55 | Termporal pattern (HP:0011008) | 2.25440161 |
| 56 | Insidious onset (HP:0003587) | 2.25440161 |
| 57 | Hyporeflexia of lower limbs (HP:0002600) | 2.23954794 |
| 58 | Neonatal onset (HP:0003623) | 2.23756518 |
| 59 | Myoglobinuria (HP:0002913) | 2.22487357 |
| 60 | Heart block (HP:0012722) | 2.22276824 |
| 61 | Focal dystonia (HP:0004373) | 2.21340204 |
| 62 | Truncal ataxia (HP:0002078) | 2.20595440 |
| 63 | Craniofacial dystonia (HP:0012179) | 2.20575781 |
| 64 | Truncus arteriosus (HP:0001660) | 2.20447221 |
| 65 | Dysdiadochokinesis (HP:0002075) | 2.19125793 |
| 66 | Impaired pain sensation (HP:0007328) | 2.18869223 |
| 67 | Abnormality of pain sensation (HP:0010832) | 2.18869223 |
| 68 | Poor eye contact (HP:0000817) | 2.18530474 |
| 69 | Obstructive sleep apnea (HP:0002870) | 2.18411883 |
| 70 | Upper limb amyotrophy (HP:0009129) | 2.18150051 |
| 71 | Distal upper limb amyotrophy (HP:0007149) | 2.18150051 |
| 72 | Prolonged partial thromboplastin time (HP:0003645) | 2.17785501 |
| 73 | Abnormal atrioventricular conduction (HP:0005150) | 2.16913054 |
| 74 | Urinary urgency (HP:0000012) | 2.14266905 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.13997266 |
| 76 | Reticulocytosis (HP:0001923) | 2.13863039 |
| 77 | Skin nodule (HP:0200036) | 2.13781695 |
| 78 | Hemiplegia (HP:0002301) | 2.13696755 |
| 79 | Abnormal eating behavior (HP:0100738) | 2.11254785 |
| 80 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10903576 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10903576 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10903576 |
| 83 | Dysmetria (HP:0001310) | 2.10168051 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.09510456 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09510456 |
| 86 | Abnormality of the periventricular white matter (HP:0002518) | 2.09370797 |
| 87 | Postural instability (HP:0002172) | 2.09350274 |
| 88 | Cholelithiasis (HP:0001081) | 2.08900571 |
| 89 | Rapidly progressive (HP:0003678) | 2.08519092 |
| 90 | Hand muscle atrophy (HP:0009130) | 2.08045303 |
| 91 | Cerebral aneurysm (HP:0004944) | 2.05873773 |
| 92 | Abnormal gallbladder morphology (HP:0012437) | 2.03930951 |
| 93 | Cerebral hemorrhage (HP:0001342) | 2.03513740 |
| 94 | Axonal loss (HP:0003447) | 2.02213413 |
| 95 | Hyperglycinemia (HP:0002154) | 2.01634190 |
| 96 | Hemiparesis (HP:0001269) | 2.01530112 |
| 97 | Difficulty running (HP:0009046) | 1.99220143 |
| 98 | Gout (HP:0001997) | 1.98350427 |
| 99 | Hypobetalipoproteinemia (HP:0003563) | 1.97812450 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 1.97691338 |
| 101 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.97152359 |
| 102 | Spastic gait (HP:0002064) | 1.96133367 |
| 103 | Oligomenorrhea (HP:0000876) | 1.95334670 |
| 104 | Hammertoe (HP:0001765) | 1.93948510 |
| 105 | Abnormality of the corticospinal tract (HP:0002492) | 1.93821612 |
| 106 | Epidermoid cyst (HP:0200040) | 1.93434555 |
| 107 | Annular pancreas (HP:0001734) | 1.92870662 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 1.92535447 |
| 109 | Hypercortisolism (HP:0001578) | 1.92531432 |
| 110 | Atrioventricular block (HP:0001678) | 1.90953905 |
| 111 | Hypoalphalipoproteinemia (HP:0003233) | 1.90919555 |
| 112 | Tetraplegia (HP:0002445) | 1.90205754 |
| 113 | Syncope (HP:0001279) | 1.88927654 |
| 114 | Abnormal EKG (HP:0003115) | 1.88765352 |
| 115 | Amblyopia (HP:0000646) | 1.88735625 |
| 116 | Scanning speech (HP:0002168) | 1.87875191 |
| 117 | Prolonged QT interval (HP:0001657) | 1.87799804 |
| 118 | Exercise-induced muscle cramps (HP:0003710) | 1.86189187 |
| 119 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.86162343 |
| 120 | Delusions (HP:0000746) | 1.85550684 |
| 121 | Epileptiform EEG discharges (HP:0011182) | 1.84819808 |
| 122 | Ventricular fibrillation (HP:0001663) | 1.84459088 |
| 123 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.84296461 |
| 124 | Abnormality of glycine metabolism (HP:0010895) | 1.84296461 |
| 125 | Systemic lupus erythematosus (HP:0002725) | 1.84200475 |
| 126 | Rigidity (HP:0002063) | 1.83374952 |
| 127 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83237223 |
| 128 | J-shaped sella turcica (HP:0002680) | 1.82522452 |
| 129 | Myopathic facies (HP:0002058) | 1.82177273 |
| 130 | Hemorrhage of the eye (HP:0011885) | 1.81950558 |
| 131 | Calf muscle hypertrophy (HP:0008981) | 1.81472693 |
| 132 | Hyperglycinuria (HP:0003108) | 1.80737927 |
| 133 | Hypsarrhythmia (HP:0002521) | 1.79472020 |
| 134 | Bundle branch block (HP:0011710) | 1.78359873 |
| 135 | Bradykinesia (HP:0002067) | 1.78065635 |
| 136 | Lower limb muscle weakness (HP:0007340) | 1.77591237 |
| 137 | Foot dorsiflexor weakness (HP:0009027) | 1.77282395 |
| 138 | Sleep apnea (HP:0010535) | 1.77031925 |
| 139 | Dysmetric saccades (HP:0000641) | 1.76173273 |
| 140 | EMG: myopathic abnormalities (HP:0003458) | 1.75660882 |
| 141 | Hypolipoproteinemia (HP:0010981) | 1.75558207 |
| 142 | Increased variability in muscle fiber diameter (HP:0003557) | 1.73688342 |
| 143 | Slow progression (HP:0003677) | 1.72885566 |
| 144 | Muscle stiffness (HP:0003552) | 1.72773467 |
| 145 | Nuclear cataract (HP:0100018) | 1.71729954 |
| 146 | Agitation (HP:0000713) | 1.71136810 |
| 147 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.71035320 |
| 148 | Mitral stenosis (HP:0001718) | 1.70969366 |
| 149 | Intention tremor (HP:0002080) | 1.70746711 |
| 150 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.70468078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.37289768 |
| 2 | EPHA4 | 3.21355853 |
| 3 | MAP3K9 | 3.15477726 |
| 4 | NTRK1 | 2.66367730 |
| 5 | DAPK2 | 2.56260580 |
| 6 | KSR2 | 2.51931630 |
| 7 | MINK1 | 2.31938622 |
| 8 | MAP2K4 | 2.06096913 |
| 9 | PHKG2 | 2.03872591 |
| 10 | PHKG1 | 2.03872591 |
| 11 | MAP3K4 | 1.98126226 |
| 12 | MARK1 | 1.96736939 |
| 13 | PAK6 | 1.94408347 |
| 14 | TRIB3 | 1.83983593 |
| 15 | PINK1 | 1.79231576 |
| 16 | GRK5 | 1.77844710 |
| 17 | ARAF | 1.59886441 |
| 18 | TESK1 | 1.59421345 |
| 19 | BCKDK | 1.57419430 |
| 20 | LMTK2 | 1.51054099 |
| 21 | MAP3K12 | 1.42966970 |
| 22 | PRKD3 | 1.39405780 |
| 23 | NTRK2 | 1.39066797 |
| 24 | CAMKK1 | 1.35197689 |
| 25 | MAP3K2 | 1.29930356 |
| 26 | CDK5 | 1.25883159 |
| 27 | RET | 1.25859691 |
| 28 | MAP2K7 | 1.19940958 |
| 29 | PAK3 | 1.17924748 |
| 30 | LATS2 | 1.17680653 |
| 31 | KSR1 | 1.17446146 |
| 32 | CASK | 1.09296196 |
| 33 | DAPK1 | 1.07006940 |
| 34 | PRKD2 | 1.06899020 |
| 35 | SIK1 | 1.04190368 |
| 36 | ERN1 | 1.03742944 |
| 37 | RIPK4 | 1.03630009 |
| 38 | MAP3K11 | 1.01271050 |
| 39 | TNK2 | 1.00906077 |
| 40 | PRKCG | 0.99714458 |
| 41 | MAP2K1 | 0.97845614 |
| 42 | UHMK1 | 0.97805098 |
| 43 | MAP3K1 | 0.97118831 |
| 44 | SIK2 | 0.96327380 |
| 45 | MAP2K6 | 0.96177401 |
| 46 | CAMK2A | 0.94794347 |
| 47 | MAP4K2 | 0.93934000 |
| 48 | MAP3K13 | 0.91106534 |
| 49 | PTK2B | 0.89522756 |
| 50 | PRKCH | 0.89333732 |
| 51 | PKN2 | 0.88854012 |
| 52 | TYRO3 | 0.87395227 |
| 53 | SGK223 | 0.87216386 |
| 54 | SGK494 | 0.87216386 |
| 55 | PIM2 | 0.85756276 |
| 56 | PDPK1 | 0.83563621 |
| 57 | LIMK1 | 0.83254022 |
| 58 | DYRK1B | 0.82660419 |
| 59 | STK38 | 0.81703980 |
| 60 | EPHA3 | 0.81387869 |
| 61 | PRPF4B | 0.79520350 |
| 62 | TESK2 | 0.78467671 |
| 63 | ICK | 0.78449585 |
| 64 | CDK14 | 0.76694561 |
| 65 | FER | 0.75524520 |
| 66 | CAMK2G | 0.74857198 |
| 67 | RAF1 | 0.74556329 |
| 68 | MAP3K7 | 0.74050029 |
| 69 | BMX | 0.73100004 |
| 70 | DDR2 | 0.71502520 |
| 71 | PDGFRA | 0.70614780 |
| 72 | DAPK3 | 0.69014629 |
| 73 | PRKCZ | 0.69014373 |
| 74 | CAMK2B | 0.68452767 |
| 75 | CAMKK2 | 0.68180167 |
| 76 | MAPK12 | 0.67484034 |
| 77 | CDK18 | 0.67371999 |
| 78 | CDK15 | 0.66996820 |
| 79 | TBK1 | 0.66973283 |
| 80 | PDK1 | 0.66507767 |
| 81 | PLK2 | 0.66329237 |
| 82 | NEK1 | 0.65176738 |
| 83 | TAOK1 | 0.64971088 |
| 84 | WNK4 | 0.64782977 |
| 85 | PKN1 | 0.63952158 |
| 86 | OBSCN | 0.63902661 |
| 87 | EPHB1 | 0.63873364 |
| 88 | DYRK1A | 0.63710604 |
| 89 | MAPK13 | 0.63668715 |
| 90 | CAMK2D | 0.61868452 |
| 91 | CAMK1 | 0.61437557 |
| 92 | MARK2 | 0.61188291 |
| 93 | MAPK15 | 0.61005151 |
| 94 | RIPK1 | 0.60968623 |
| 95 | CDC42BPA | 0.60908419 |
| 96 | MAPKAPK3 | 0.60665330 |
| 97 | RPS6KA2 | 0.59390295 |
| 98 | STK11 | 0.57190780 |
| 99 | PTK2 | 0.56808455 |
| 100 | PRKAA1 | 0.55935995 |
| 101 | INSRR | 0.55677810 |
| 102 | FES | 0.55607911 |
| 103 | CDK11A | 0.54078663 |
| 104 | PDK3 | 0.53899093 |
| 105 | PDK4 | 0.53899093 |
| 106 | PRKCE | 0.53772601 |
| 107 | EPHB2 | 0.53449943 |
| 108 | CDK19 | 0.53044493 |
| 109 | SGK3 | 0.52959291 |
| 110 | CSNK1G2 | 0.52776420 |
| 111 | MAP3K6 | 0.51257616 |
| 112 | FGFR4 | 0.51051338 |
| 113 | TAOK3 | 0.50253066 |
| 114 | ERBB4 | 0.47635523 |
| 115 | TTN | 0.47363429 |
| 116 | PRKACG | 0.47136995 |
| 117 | WNK1 | 0.46945760 |
| 118 | MAPK7 | 0.45226666 |
| 119 | OXSR1 | 0.44660913 |
| 120 | MUSK | 0.44507908 |
| 121 | CAMK1D | 0.44488069 |
| 122 | CAMK4 | 0.44353728 |
| 123 | MYLK | 0.44041519 |
| 124 | PRKD1 | 0.43445179 |
| 125 | SGK1 | 0.42956132 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95843649 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.75265051 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.39708413 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.20087058 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.17489669 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 1.79536273 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.79179060 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76743107 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.70487275 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68861128 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.68483639 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.65398750 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.62302407 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.54320902 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49579780 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48811585 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.47772004 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47523719 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.44868171 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41414280 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40591949 |
| 22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.40559301 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.40510467 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.40287624 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.37848856 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34999070 |
| 27 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.34884572 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.34139011 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.30863040 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30695315 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.29531990 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.29500457 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28611278 |
| 34 | Long-term potentiation_Homo sapiens_hsa04720 | 1.20629939 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19372752 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.18018883 |
| 37 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.17979884 |
| 38 | Salivary secretion_Homo sapiens_hsa04970 | 1.15536593 |
| 39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.15191606 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.14065053 |
| 41 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13921142 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.13009328 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07130837 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.05782332 |
| 45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.04633861 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04130057 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.02524683 |
| 48 | Taste transduction_Homo sapiens_hsa04742 | 0.97254755 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 0.95822155 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94259837 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 0.94212113 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.94008406 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.93241829 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88497079 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88319014 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86815034 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84386483 |
| 58 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84066039 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83388787 |
| 60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83147233 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82018566 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 0.81565594 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81328254 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78204351 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75776595 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75303154 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74224463 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73691550 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.73386156 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.73045780 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72449989 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72274358 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.71765519 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70958868 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.70001218 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68764143 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.68560567 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68055596 |
| 79 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67562545 |
| 80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65969951 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63828012 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63586071 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63570953 |
| 84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63129531 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62651262 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62163795 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61633864 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60453146 |
| 89 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59217369 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58565007 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58251607 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57966801 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57892025 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57777870 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57031602 |
| 96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56489704 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54856867 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.54437417 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54177924 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52820196 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51102604 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50630936 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50370984 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49659568 |
| 105 | Axon guidance_Homo sapiens_hsa04360 | 0.49327763 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.48290890 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47608566 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47413298 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47260942 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.47137099 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.47011264 |
| 112 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.46469757 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46391405 |
| 114 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46312566 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46252390 |
| 116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45674074 |
| 117 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45290621 |
| 118 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44952617 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44749782 |
| 120 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44332839 |
| 121 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43902857 |
| 122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42479380 |
| 123 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41557000 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41491217 |

